Transcription of Dementia Clinical Practice Guideline
{{id}} {{{paragraph}}}
current Pharmacologic Treatment of Dementia : A Clinical PracticeGuideline from the american College of Physicians and the AmericanAcademy of family PhysiciansAmir Qaseem, MD, PhD, MHA; Vincenza Snow, MD; J. Thomas Cross Jr., MD, MPH; Mary Ann Forciea, MD; Robert Hopkins Jr., MD;Paul Shekelle, MD, PhD; Alan Adelman, MD; David Mehr, MD, MS; Kenneth Schellhase, MD, MPH; Doug Campos-Outcalt, MD, MPA;Pasqualina Santaguida, PhD; Douglas K. Owens, MD, MS; and the Joint american College of Physicians/ american academy of FamilyPhysicians Panel on Dementia *Description:The american College of Physicians and AmericanAcademy of family Physicians developed this Guideline to presentthe available evidence on current pharmacologic treatmentof :The targeted literature search included evidence relatedto the effectiveness of 5 Food and Drug Administration approved pharmacologic therapies for Dementia for outcomes inthe domains of cognition, global function, behavior/mood,andquality of life/activities of daily 1:Clinicians should base the decision to initiatea trial of therapy with a cholinesterase inhibitor or memantine onindividualized assessment.
Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}